Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Kempharm Inc Cmn (KMPH)

4.20 -0.10 (-2.33%)

2/28/2017  11:15am

Open:

4.30

Pre. Close:

4.30

High:

4.30

Low:

4.15

Volume:

15,735

Market Cap:

61.51M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.45 - 4.58

4.58 - 4.71

Low:

3.75 - 3.82

3.82 - 3.89

Close:

4.2 - 4.36

4.36 - 4.51

Technical analysis  (as of: 2017-02-28 10:55:55 AM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 5.08     One year: 5.93

Support:

Support1: 3.61    Support2: 3.15

Resistance:

Resistance1: 4.35    Resistance2: 5.08

Pivot:

3.81

Moving Averages:

MA(5): 3.97     MA(20): 3.79

MA(100): 3.72     MA(250): 6.47

MACD:

MACD(12,26): 0.13     Signal(12,26,9): 0.09

%K %D:

%K(14,3): 83.37     %D(3): 72.03

RSI:

RSI(14): 65.22

52-Week:

High: 19.75  Low: 2.90  Change(%): -74.5

Average Vol(K):

3-Month: 58  10-Days 39

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
KMPH has closed below upper band by 11.6%. Bollinger Bands are 20.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 28 Feb 2017 12:31:41 GMT
KemPharm, Inc. to Report Fourth Quarter and Year End 2016 Results

Wed, 04 Mar 2015 13:10:49 GMT
KemPharm, Inc. Appoints Tracy M. Woody as Chief Commercial Officer

Mon, 23 Jan 2017 16:39:37 GMT
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation ...

Fri, 06 May 2016 14:15:00 GMT
Analyst Downgrades: KemPharm Inc, Endo International plc, and FireEye Inc

Tue, 01 Nov 2016 20:24:59 GMT
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

14.65

Shares Float (M)

6.26

% Held by Insiders

17.67

% Held by Institutions

41.40

Shares Short (K)

633

Shares Short Prior Month (K)

619

Stock Financials

EPS

-1.430

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

-0.670

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-24.8

Return on Equity (ttm)

-133.2

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.102

Qtrly Earnings Growth

Operating Cash Flow (M)

-26.53

Levered Free Cash Flow (M)

-14.78

FoxReading.com

Valuation

P/E

-2.90

P/E Growth Ratio

-0.03

P/BV

-6.19

P/S

P/CF

-2.29

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.